# Genotype-Guided Warfarin Therapy Trial

> **NCT00904293** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 109 (actual)

## Conditions studied

- Atrial Fibrillation
- Deep Vein Thrombosis
- Pulmonary Embolism
- Artificial Heart Valve

## Interventions

- **OTHER:** Genotype-guided dose determination
- **OTHER:** Non-genotype guided warfarin dosing

## Key facts

- **NCT ID:** NCT00904293
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2016-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00904293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00904293, "Genotype-Guided Warfarin Therapy Trial". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00904293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*